Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 42708-054

5 FDA label images from Qpharma, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 42708-054). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Qpharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula For Venlafaxine Hydrochloride (Image 1)

Structural Formula For Venlafaxine Hydrochloride (Image 1)
Chemical structure of venlafaxine hydrochloride, showing the molecular arrangement including a cyclohexane ring, a methoxy-substituted aromatic ring, a dimethylamino group, and a hydrochloride component.*
FDA Label Image

1 (Image 2)

1 (Image 2)
A scatter plot chart depicting fold changes and 90% confidence intervals of pharmacokinetic parameters (Cmax and AUC) for venlafaxine and its metabolite ODV across various special populations. Populations include hepatic impairment, renal impairment, CYP2D6 polymorphism, age over 60 years, and gender comparison. The x-axis shows change relative to the reference value, ranging from 0 to 3.5, centered at 1.*
FDA Label Image

2 (Image 3)

2 (Image 3)
A pharmacokinetic interaction chart showing the effects of various interacting drugs on venlafaxine and its analytes. It plots fold change and 90% confidence intervals for parameters like Cmax, AUC, and ODV relative to a reference value, highlighting how compounds such as ethanol, diazepam, cimetidine, ketoconazole, indinavir, metoprolol, imipramine, and lithium impact venlafaxine exposure.*
FDA Label Image

3 (Image 4)

3 (Image 4)
A scatter plot chart illustrating the fold change and 90% confidence intervals for various pharmacokinetic parameters (Cmax and AUC) of multiple interacting drugs and their analytes. The x-axis represents change relative to the reference value, ranging from 0 to 3, while the y-axis lists interacting drugs and analytes, including ethanol, diazepam, alprazolam, indinavir, metoprolol, risperidone, imipramine, haloperidol, caffeine, tolbutamide, and lithium.*
FDA Label Image

Label (42708 054 30 Image)

Label (42708 054 30 Image)
Label for Venlafaxine Hydrochloride Extended-Release Capsules, USP 75 mg, showing package with 30 tablets. The label includes dosage instructions space, storage instructions, distributor QPharma, Inc., and notes that the product is a sample, not for sale, and is Rx only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.